viroLOGICAL

viroLOGICAL

By Florian Krammer & PodcastwerkstattScienceMedicineHealth & FitnessEducationLife Sciences
Download on the App Store

viroLOGICAL episodes

  • #1 – Rabies Virus: One of the Deadliest Infections

    In this episode of viroLOGICAL, Florian Krammer explains rabies, one of the deadliest infectious diseases known. He describes what the rabies virus is, how it is transmitted mainly through bites and scratches, and why symptoms almost always lead to death once they appear. The episode covers how the virus spreads through the nervous system to the brain, which symptoms typically occur, and why incubation times can range from days to even years. It also explains how post-exposure prophylaxis can prevent the disease if given in time, how rabies is controlled through vaccination of pets and wildlife, and why the virus, despite its severity, does not pose a realistic pandemic threat.

    Rabies case in the UK due to dog scratch in Morocco: https://www.theguardian.com/uk-news/2025/jun/18/person-dies-of-rabies-in-yorkshire-after-contact-with-dog-in-morocco

    Rabies cases in the US through bats: https://www.cdc.gov/mmwr/volumes/71/wr/mm7101a5.htm?scid=mm7101a5w

    Information about rabies free countries: https://worldpopulationreview.com/country-rankings/rabies-free-countries

    NPR report about person who died due to refusal to get rabies post exposure prophylaxis: https://www.npr.org/2021/09/29/1041457232/rabies-illinois-man-death-rare-public-health

    CDC rabies information: https://www.cdc.gov/rabies/php/protecting-public-health/index.html

    Rabid: A cultural history of the world's most diabolic virus; Bill Wasik, Monica Murphy; ISBN:9780143123576, 0143123572

    +++++

    Support viroLOGICAL on Steady:

    You can support the podcast via our German Steady page:
    https://steady.page/virologisch/

    Questions, feedback or topic suggestions?

    Feel free to contact us at: [email protected]

    +++++

    Krammer laboratory information

    Krammer Laboratory at the Icahn School of Medicine at Mount Sinai

    https://labs.icahn.mssm.edu/krammerlab/

    Ludwig Boltzmann Institute for Science Outreach and Pandemic Preparedness

    https://soap.lbg.ac.at/

    Ignaz Semmelweis Institute

    https://semmelweisinstitute.ac.at/

    +++++

    Conflict of interest statement

    The Icahn School of Medicine at Mount Sinai has filed patent applications relating to influenza virus vaccines and therapeutics, SARS-CoV-2 serological assays and NDV-based SARS-CoV-2 vaccines which name me as inventor. Mount Sinai has spun out a company, CastleVax, to commercialize NDV-based SARS-CoV-2 vaccines and I am named as co-founder and scientific advisory board member of that company.

    I have previously consulted for Curevac, Merck, Gritstone, Sanofi, Seqirus, GSK and Pfizer and I am currently consulting for 3rd Rock Ventures (US) and Avimex (Mexico).

    My laboratory has been collaborating in the past with Pfizer on animal models of SARS-CoV-2 and with GlaxoSmithKline and VIR on the development of influenza virus vaccines and therapeutics and we are currently collaborating with Dynavax, Inspirevax and Inimmune on development of influenza virus vaccines.

    My work in the on immunity and infectious diseases in the US is supported by the National Institutes of Health, but also by FluLab and Tito’s Handmade Vodka. In the past I have also received funding from the Bill and Melinda Gates Foundation, PATH and the US Department of Defense.

    My work in Austria is supported by the Ludwig Boltzmann Gesellschaft and by the Ignaz Semmelweis Institute through the Medical University of Vienna.

    21 min
  • #0 – What Are Viruses?

    In the first episode of viroLOGICAL, Florian Krammer takes a fundamental look at viruses: What are viruses and why are they not considered living organisms? He explains how viruses replicate inside host cells, how they were first discovered, and why their size, shape and genetic makeup can differ so widely. The episode also covers key concepts like transmission routes, incubation periods, R number, epidemics, pandemics and zoonoses, and discusses why factors such as climate change, globalization and closer contact between humans and animals increase the risk of future outbreaks.

    ProMED: https://www.promedmail.org/

    Krammer Laboratory at the Icahn School of Medicine at Mount Sinai: https://labs.icahn.mssm.edu/krammerlab/

    Ludwig Boltzmann Institute for Science Outreach and Pandemic Preparedness: https://soap.lbg.ac.at/

    This institute also has a monthly online One Health seminar geared towards the general public that is open for everybody: https://soap.lbg.ac.at/upcoming-one-health-seminar/

    Ignaz Semmelweis Institute: https://semmelweisinstitute.ac.at/

    +++++

    Support viroLOGICAL on Steady:

    You can support the podcast via our German Steady page:
    https://steady.page/virologisch/

    Questions, feedback or topic suggestions?

    Feel free to contact us at: [email protected]

    +++++

    Krammer laboratory information

    Krammer Laboratory at the Icahn School of Medicine at Mount Sinai

    https://labs.icahn.mssm.edu/krammerlab/

    Ludwig Boltzmann Institute for Science Outreach and Pandemic Preparedness

    https://soap.lbg.ac.at/

    Ignaz Semmelweis Institute

    https://semmelweisinstitute.ac.at/

    +++++

    Conflict of interest statement

    The Icahn School of Medicine at Mount Sinai has filed patent applications relating to influenza virus vaccines and therapeutics, SARS-CoV-2 serological assays and NDV-based SARS-CoV-2 vaccines which name me as inventor. Mount Sinai has spun out a company, CastleVax, to commercialize NDV-based SARS-CoV-2 vaccines and I am named as co-founder and scientific advisory board member of that company.

    I have previously consulted for Curevac, Merck, Gritstone, Sanofi, Seqirus, GSK and Pfizer and I am currently consulting for 3rd Rock Ventures (US) and Avimex (Mexico).

    My laboratory has been collaborating in the past with Pfizer on animal models of SARS-CoV-2 and with GlaxoSmithKline and VIR on the development of influenza virus vaccines and therapeutics and we are currently collaborating with Dynavax, Inspirevax and Inimmune on development of influenza virus vaccines.

    My work in the on immunity and infectious diseases in the US is supported by the National Institutes of Health, but also by FluLab and Tito’s Handmade Vodka. In the past I have also received funding from the Bill and Melinda Gates Foundation, PATH and the US Department of Defense.

    My work in Austria is supported by the Ludwig Boltzmann Gesellschaft and by the Ignaz Semmelweis Institute through the Medical University of Vienna.

    46 min
  • Trailer

    Florian Krammer is a virologist and vaccine developer. In his podcast viroLOGICAL he will talk about viruses on a weekly basis – from historical pandemics to current developments.

    Krammer laboratory information

    Krammer Laboratory at the Icahn School of Medicine at Mount Sinai

    https://labs.icahn.mssm.edu/krammerlab/

    Ludwig Boltzmann Institute for Science Outreach and Pandemic Preparedness

    https://soap.lbg.ac.at/

    Ignaz Semmelweis Institute

    https://semmelweisinstitute.ac.at/

    +++++

    Conflict of interest statement

    The Icahn School of Medicine at Mount Sinai has filed patent applications relating to influenza virus vaccines and therapeutics, SARS-CoV-2 serological assays and NDV-based SARS-CoV-2 vaccines which name me as inventor. Mount Sinai has spun out a company, CastleVax, to commercialize NDV-based SARS-CoV-2 vaccines and I am named as co-founder and scientific advisory board member of that company.

    I have previously consulted for Curevac, Merck, Gritstone, Sanofi, Seqirus, GSK and Pfizer and I am currently consulting for 3rd Rock Ventures (US) and Avimex (Mexico).

    My laboratory has been collaborating in the past with Pfizer on animal models of SARS-CoV-2 and with GlaxoSmithKline and VIR on the development of influenza virus vaccines and therapeutics and we are currently collaborating with Dynavax, Inspirevax and Inimmune on development of influenza virus vaccines.

    My work in the on immunity and infectious diseases in the US is supported by the National Institutes of Health, but also by FluLab and Tito’s Handmade Vodka. In the past I have also received funding from the Bill and Melinda Gates Foundation, PATH and the US Department of Defense.

    My work in Austria is supported by the Ludwig Boltzmann Gesellschaft and by the Ignaz Semmelweis Institute through the Medical University of Vienna.

    2 min

About viroLOGICAL

From the publisher's feed

Florian Krammer is a virologist and vaccine developer. In his podcast viroLOGICAL he will talk about viruses on a weekly basis – from historical pandemics to current developments.